James R Sulat - Net Worth and Insider Trading
James R Sulat Net Worth
The estimated net worth of James R Sulat is at least $9,906 dollars as of 2024-05-08. James R Sulat is the Director of Mallinckrodt PLC and owns about 82,553 shares of Mallinckrodt PLC (MCKPF) stock worth over $9,906. Details can be seen in James R Sulat's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James R Sulat has not made any transactions after 2023-03-15 and currently still holds the listed stock(s).
Transaction Summary of James R Sulat
James R Sulat Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James R Sulat owns 8 companies in total, including Arch Therapeutics Inc (ARTH) , AMAG Pharmaceuticals Inc (AMAG) , and Momenta Pharmaceuticals Inc (MNTA) among others .
Click here to see the complete history of James R Sulat’s form 4 insider trades.
Insider Ownership Summary of James R Sulat
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ARTH | Arch Therapeutics Inc | 2019-12-20 | director |
AMAG | AMAG Pharmaceuticals Inc | 2020-06-02 | director |
MNTA | Momenta Pharmaceuticals Inc | 2019-06-19 | director |
2010-04-21 | director & 10 percent owner | ||
2004-03-02 | Executive Vice President | ||
2021-01-02 | director | ||
2022-06-16 | director | ||
2023-03-15 | director |
James R Sulat Latest Holdings Summary
James R Sulat currently owns a total of 1 stock. James R Sulat owns 82,553 shares of Mallinckrodt PLC (MCKPF) as of March 15, 2023, with a value of $9,906.
Latest Holdings of James R Sulat
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MCKPF | Mallinckrodt PLC | 2023-03-15 | 82,553 | 0.12 | 9,906 |
Holding Weightings of James R Sulat
James R Sulat Form 4 Trading Tracker
According to the SEC Form 4 filings, James R Sulat has made a total of 1 transactions in Mallinckrodt PLC (MCKPF) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Mallinckrodt PLC is the acquisition of 30,000 shares on March 15, 2023, which cost James R Sulat around $254,400.
Insider Trading History of James R Sulat
- 1
James R Sulat Trading Performance
GuruFocus tracks the stock performance after each of James R Sulat's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James R Sulat is -89.58%. GuruFocus also compares James R Sulat's trading performance to market benchmark return within the same time period. The performance of stocks bought by James R Sulat within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James R Sulat's insider trading performs compared to the benchmark.
Performance of James R Sulat
James R Sulat Ownership Network
Ownership Network List of James R Sulat
Ownership Network Relation of James R Sulat
James R Sulat Owned Company Details
What does Arch Therapeutics Inc do?
Who are the key executives at Arch Therapeutics Inc?
James R Sulat is the director of Arch Therapeutics Inc. Other key executives at Arch Therapeutics Inc include director & President & CEO Terrence W Norchi , CFO and Treasurer Michael S Abrams , and Vice President & Sales Dan Yrigoyen .
Arch Therapeutics Inc (ARTH) Insider Trades Summary
Over the past 18 months, James R Sulat made no insider transaction in Arch Therapeutics Inc (ARTH). Other recent insider transactions involving Arch Therapeutics Inc (ARTH) include a net purchase of 10,292 shares made by Michael S Abrams , a net purchase of 10,292 shares made by Laurence Hicks , and a net purchase of 6,862 shares made by Terrence W Norchi .
In summary, during the past 3 months, insiders sold 0 shares of Arch Therapeutics Inc (ARTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arch Therapeutics Inc (ARTH) were sold and 27,446 shares were bought by its insiders, resulting in a net purchase of 27,446 shares.
Arch Therapeutics Inc (ARTH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arch Therapeutics Inc Insider Transactions
James R Sulat Mailing Address
Above is the net worth, insider trading, and ownership report for James R Sulat. Currently GuruFocus does not have mailing address information for James R Sulat.